Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development
Pu Wang, … , Scott E. Parnell, Yue Xiong
Pu Wang, … , Scott E. Parnell, Yue Xiong
Published July 25, 2019
Citation Information: J Clin Invest. 2019;129(10):4393-4407. https://doi.org/10.1172/JCI129107.
View: Text | PDF
Research Article Development Genetics

Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development

  • Text
  • PDF
Abstract

3-M primordial dwarfism is an inherited disease characterized by severe pre- and postnatal growth retardation and by mutually exclusive mutations in 3 genes, CUL7, OBSL1, and CCDC8. The mechanism underlying 3-M dwarfism is not clear. We showed here that CCDC8, derived from a retrotransposon Gag protein in placental mammals, exclusively localized on the plasma membrane and was phosphorylated by CK2 and GSK3. Phosphorylation of CCDC8 resulted in its binding first with OBSL1, and then CUL7, leading to the membrane assembly of the 3-M E3 ubiquitin ligase complex. We identified LL5β, a plasma membrane protein that regulates cell migration, as a substrate of 3-M ligase. Wnt inhibition of CCDC8 phosphorylation or patient-derived mutations in 3-M genes disrupted membrane localization of the 3-M complex and accumulated LL5β. Deletion of Ccdc8 in mice impaired trophoblast migration and placental development, resulting in intrauterine growth restriction and perinatal lethality. These results identified a mechanism regulating cell migration and placental development that underlies the development of 3-M dwarfism.

Authors

Pu Wang, Feng Yan, Zhijun Li, Yanbao Yu, Scott E. Parnell, Yue Xiong

×

Figure 4

The Wnt pathway inhibits CCDC8 phosphorylation and 3-M complex assembly.

Options: View larger image (or click on image) Download as PowerPoint
The Wnt pathway inhibits CCDC8 phosphorylation and 3-M complex assembly....
(A) HA-tagged wild-type or mutant CCDC8 was coexpressed with OBSL1-FLAG, followed by IP and Western analyses to examine CCDC8-OBSL1 protein interaction using indicated antibodies. (B and C) U2OS cells with endogenous OBSL1 3×FLAG-tagged by CRISPR were treated with CK2 inhibitor CX-4945 (B) or GSK3 inhibitor CHIR-98014 (C) for the indicated time. The binding between OBSL1 with CUL7 and CCDC8 was examined by IP and Western analyses using indicated antibodies. (D) mKate-fused wild-type or mutant CCDC8 was cotransfected with CUL7-mTagBFP and OBSL1-EGFP into U2OS cells, followed by confocal microscopic examination. Scale bars: 10 μm. (E) U2OS cells were treated with recombinant Wnt3a or IGF1. Cell lysates were subjected to 6% Zn Phos-tag PAGE (top panel) or 10% conventional SDS-PAGE. Indicated proteins were detected by Western blot. (F) U2OS with endogenous CCDC8 3×FLAG-tagged by CRISPR were treated with recombinant Wnt3a. Endogenous CCDC8 was enriched by anti-FLAG immunoprecipitation and CCDC8 phosphorylation was detected by anti–p-Ser142 or anti–p-Ser146 antibody. (G) U2OS cells expressing endogenous 3×FLAG-OBSL1 were treated with recombinant Wnt3a for the indicated time. The binding between OBSL1 with CUL7 and CCDC8 was determined by IP and Western analyses.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts